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ABSTRACT: Discrete palladium(II) complexes featuring pur-
posely designed phosphine ligands can promote depropargyla-
tion and deallylation reactions in cell lysates. These complexes
perform better than other palladium sources, which apparently
are rapidly deactivated in such hostile complex media. This good
balance between reactivity and stability allows the use of these
discrete phosphine palladium complexes in living mammalian
cells, whereby they can mediate similar transformations. The
presence of a phosphine ligand in the coordination sphere of
palladium also provides for the introduction of targeting groups,
such as hydrophobic phosphonium moieties, which facilitate the
accumulation of the complexes in mitochondria.
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The functioning of the cell is dependent on the regulatedaction of thousands of enzymes, many of which require
metal cofactors for their activity. In most of the cases, the metal
works either as a Lewis acid or as an electron-transfer center.1
In recent years, there have been impressive advances toward the
development of artificial metalloenzymes capable of achieving
transformations that do not occur in nature,2−4 with a special
emphasis on those promoted by late transition metals.5,6
However, translating these metalloprotein catalysts to living
settings is far from obvious and has only been proved in
isolated cases and in bacterial periplasms.7,8
More success has been attained with discrete, small
transition-metal complexes that are capable of crossing cell
membranes and, thereby, able to promote intracellular
transformations.9−13 This is the case for several ruthenium(II)
complexes that can mediate the uncaging of allyl-carbamate
(alloc) protected amines in living mammalian cells.14−17
Particularly exciting is the possibility of using Pd catalysts in
biological contexts, because of the well-known transformative
power of palladium in organometallic chemistry.18,19 However,
the use of palladium complexes in the complex environment of
living cells is seriously compromised by many issues, including
solubility, stability, biorthogonal reactivity, or toxicity. There-
fore, most applications that have been described so far involve
the use Pd nanostructures or mesostructures, rather than
discrete complexes. Hence, Bradley, Unciti-Broceta, and co-
workers have claimed that small Pd(0) microspheres can induce
depropargylation reactions or even Suzuki−Miyaura cross-
coupling in biological settings,20,21 and Chen reported that
freshly made palladium nanoparticles can promote similar
reactions.22
Discrete palladium complexes have also been used, but only
sporadically, and with somewhat differing results. Therefore,
Chen and co-workers have shown that commercial Pd
precursors such as Pd(dba)2 and Pd2(allyl)2Cl2 can cleave
propargyloxy groups (poc) in PBS at 37 °C, and even in HeLa
cells.23 However, a recent study by the Weissleder group reveals
that these commercial Pd sources perform poorly when using
standard tissue culture (HBSS and MEM) as reaction milieu.
Remarkably, these authors were able to obtain good yields in
alloc-removing reactions by using bis[tris(2-furyl)phosphine]-
palladium(II) dichloride as a catalyst, although stability and
solubility issues precluded direct use of the complex in living
settings. This problem was solved by encapsulating the metal
complex within a biocompatible polymer (see Scheme 1).24
The above results raise doubts on whether discrete palladium
complexes can indeed be used as catalysts in complex biological
media and in living cells. Such small-sized palladium complexes
are very attractive, because of their well-defined nature, and the
possibility of manipulating the ligands to tune solubility,
stability, and reactivity properties, and eventually favor cell
transport and intracellular targeting.
Herein, we demonstrate that discrete palladium complexes
with designed phosphine ligands can promote propargyl and
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alloc cleavage reactions in cell lysates, and even in living
mammalian cells. Importantly, appropriate engineering of the
ligand allows the mitochondria accumulation of an active
palladium catalyst.
Given that previous studies did not clearly establish the in
vitro reactivity of different palladium sources to cleave
propargyloxy groups, we investigated the catalytic performance
of several complexes in PBS and cell lysates.
In addition to standard commercial species, such as
[Pd(allyl)Cl]2 (Pd1), Pd(OAc)2 (Pd2), and Pd2(dba)3
(Pd3),23−25 we purposely made a series of Pd(II) complexes
(Pd4−Pd9) that exhibited designed pyridine, thioether, or
phosphine ligands (see Figure 1 and pp S3−S8 in the
Supporting Information). In the case of the phosphine-
containing derivatives, we built complexes with neutral (Pd6),
anionic (Pd7), or positively charged phosphonium tethers
(Pd8 and Pd9).
Instead of the typical assay consisting of the cleavage of a
propargylic carbamate, we studied the depropargylation of
phenol derivative 1. We chose this probe because of its good
aqueous solubility, ease of synthesis, and good separation
properties by HPLC-MS. Furthermore, in contrast to standard
Rhodamine probes, it presents only one propargylic appendage,
thereby simplifying the analysis.
The reactions were carried out using a 200 μM solution of
substrate 1 and 10 mol % of the Pd sources in either water, PBS
(phosphate buffered saline, pH 7.2), or HeLa cell lysates for 24
h at 37 °C (see Figure 1 and the Supporting Information (pp
S9−S13). Pd1 and Pd2, and the complexes bearing pyridine
and methionine ligands (Pd4 and Pd5) provided good yields of
2, in both water and PBS; however, in cell lysates, the
conversion was extremely low. Likely, these palladium
complexes do not survive to the complex mixture of
components present in a cell lysate, and decompose to form
inactive Pd species.26 The palladium complexes with phosphine
ligands Pd6−Pd9 gave lower conversions in water, with yields
ranging from ca. 40% for Pd6 to ca. 15% for Pd7−Pd9, and
performed very poorly in PBS, likely because of the low
solubility of the complexes in high-ionic-strength media.
Scheme 1. Previous Examples of In Cellulo Uncaging of Poc and Alloc Probes Mediated by Pd Catalysts and Reactions
Described in This Work
Figure 1. (a) Representation of the uncaging reaction of 1, and (b) bar diagram representation of the yields obtained for each catalyst under
biological compatible conditions in water, PBS buffer, and cell lysates. Reaction conditions: 1 (0.2 mmol, 1 equiv), Pd (0.02 mmol, 0.1 equiv) in 1
mL, 37 °C, 24 h (mean ± s.e.m, n = 2). (c) Pd catalysts used in this work for the study of their catalytic performance in biological compatible media
and in living cells. Yields were calculated by RP-HPLC-MS, using coumarin as an internal standard.
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However, complexes Pd6, Pd7, and Pd9 were able to
promote the depropargylation reaction in cell lysates. Although
the yields were low, their performance is better than that of the
other palladium sources (Pd1−Pd5). Possibly, albeit a
phosphine ligand is not the best one from a reactivity point
of view, the corresponding palladium complexes are more
stable and can better resist hostile media such as that present in
cell lysates.
We also investigated the ability of these latter phosphine
palladium reagents to remove alloc protecting groups, which is
a process that likely involves Pd(0) reagents. The uncaging
reaction was evaluated in substrate 3, in the absence or
presence of added reducing agents (see Figure 2a and the
Supporting Information (pp S9−S13)). The reactions were
performed using 200 μM solutions of 3 in water, 10 mol % of
the palladium complexes, at 37 °C, in the absence or presence
of 2 mM of NaAsc or 0.4 mM of GSH, and monitored by high-
performance liquid chromatograpy-mass spectroscopy (HPLC-
MS) at 1, 3, 6, and 24 h. In the absence of the additives, the
yields were very poor; however, in the presence of NaAsc, we
obtained yields of >50% and >30%, using Pd7 and Pd9,
respectively (24 h). With GSH, the reaction with Pd7 was more
efficient, and hence, we observed 60% yield after 1 h and 94%
after 24 h. When the experiments were performed in the
presence of cell lysates, Pd7 and Pd9 led to product yields of
33% and 24% after 24 h.
With further additions of GSH (0.4 mM) to the lysate, the
yields were not very different (24% and 22%, respectively; see
Figure 2).
The above results confirm that phosphine palladium(II)
complexes can promote depropargylation and deallylation
reactions in water with good yields. Although in cell lysates,
the efficiency is considerably lower, we were intrigued to know
whether the reactions could be achieved inside living cells, as
the intracellular environment does not necessarily parallel that
of a cell lysate. A key element to take into account before
moving to intracellular reactions is uptake of the potential
catalysts. Inductively coupled plasma−mass spectroscopy (ICP-
MS) analysis of cellular extracts (Vero cells), obtained after
extensive washing and lytic treatment, revealed a higher amount
of palladium after the addition of complexes Pd6−Pd9 than of
species Pd1−Pd5 (see Figures S12 and S13 in the Supporting
Information). Importantly, cell viability tests (MTT in Vero
cells, 24 h) demonstrated that the phosphine-containing
complexes are essentially nontoxic below 50 μM, and some
of them can be used even at higher concentrations (see Figure
S14 in the Supporting Information). While substrate 1 was
good for in vitro studies, the change in fluorescence after the
Figure 2. (a) Uncaging of 3, (b) plot of the yields of reaction obtained with catalysts (i) Pd7 and (ii) Pd9 at 1, 3, 6, and 24 h in only water, or with
additives: NaAsc (2 mM) or GSH (0.4 mM) (reaction conditions: 3 (0.2 mmol, 1 equiv), Pd complex (0.02 mM, 0.1 equiv) in 1 mL, 37 °C, 24 h),
and (c) uncaging reaction in cell lysates (green column) and in cell lysate +0.4 mM of GSH (red column) promoted by catalysts Pd7 and Pd9.
[Reaction conditions: 10 (0.2 mmol, 1 equiv), Pd (0.02 mM, 0.1 equiv) in 1 mL, 37 °C, 24 h.] Inset shows Pd7 and Pd9. Yields were calculated by
RP-HPLC-MS, using coumarine as an internal standard (mean ± s.e.m., n = 2).
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reactions is not strong enough for an appropriate monitoring in
cellular settings. Therefore, we changed to the propargylated
probe 5, which, after uncaging, generates a product 6 that emits
at 635 nm when excited in the far-ultraviolet (far-UV) region
(see Figure 3a).27
The experiments were carried out by incubation of Vero cells
at a final concentration of 50 μM of the probe 5 in culture
medium containing 5% fetal bovine serum (FBS-DMEM) for
30 min at 37 °C. The milieu was removed, and cells were
washed twice with FBS-DMEM to ensure removal of
extracellular probe. Pd reagents (50 μM) were then added in
fresh media (0.1% dimethyl sulfoxide (DMSO)), and, after 30
min, cells were imaged by wide-field fluorescence microscopy.
While in the experiments with Pd sources (Pd1−Pd3 and
complexes Pd4 and Pd5), we observed almost negligible red
emission (Figure S15 in the Supporting Information), with
species Pd6−Pd8, equipped with phosphine ligands, we
detected strong red emission due to the release of the product
6 inside Vero cells (Figure 3b). The overlap between the
absorption of the pyrene unit in Pd9 and that of product 6
precluded the analysis of the reaction with this complex.
Overall, these results are consistent with the in vitro studies and
confirm that the phosphine ligands are beneficial for observing
“in cell” reactivity, likely because the complexes present a good
balance between reactivity and stability in the cellular milieu.
Considering the amount of palladium that was present in
cells, as measured by ICP-MS of cell extracts after extensive
washing steps, and associating the normalized fluorescence
intensity with the amount of product, using calibration curves
(see the Supporting Information (p S18)), it is possible to
estimate whether there is some turnover. Indeed, for Pd7, we
calculated an average TON of 10, whereas for Pd8, it is >5,
suggesting that catalytic cycles can operate in cellular settings.
The cellular reactions can also be carried out in mammalian
cells other than Vero, such as HeLa (see Figure S17 in the
Supporting Information). We also checked an inverse protocol
in which cells are first treated with the palladium reagents, and
the probe is added after 30 min, after the corresponding
washing steps. However, in these cases, we did not observe
fluorescence, likely because the palladium complexes, over time,
are converted to species that are not enough active in the
depropargylation process.
We next explored the removal of alloc groups inside living
HeLa cells, in this case, using the caged Rhodamine 110
derivative 7, which is essentially nonfluorescent, but emits
green light after removing the alloc protecting groups. Initial
experiments were carried out by mixing HeLa cells with 7 (50
μM in FBS-DMEM) for 30 min, 2-fold washing with FBS-
DMEM, and addition of the Pd complexes. After 30 min at 37
°C, cells were visualized under the microscope. As in the case of
the depropargylation reaction, the complexes Pd1−Pd5 raised
only very low intracellular fluorescence, however, with species
Pd6−Pd8, we could observe strong intracellular green
fluorescence (see Figure S18 in the Supporting Information).
Inverting the order of addition, first the palladium complexes,
and after 30 min, washing and addition of the probe 7, we
detected intracellular fluorescence, but only with complexes
Pd8 (see Figure S19 in the Supporting Information) and Pd9
(Figure 4). Similar results were obtained in Vero cells (see
Figure S20 in the Supporting Information).
In the case of Pd9, the presence of a pyrene group in the
ligand structure allowed a direct monitoring of the species in
living cells. As shown in Figure 4, the blue emission of living
cells after addition of this complex shows a very good co-
localization with the red color of a mitotracker (Figure 4b,
panels (i)−(iii)). This was further confirmed by ICP-MS
analysis of cells lysed under conditions that allowed the
isolation of the mitochondria from the rest of the cytoplasmic
mass. As indicated in Figure 4e, Pd9 presents a substantially
higher mitochondrial accumulation than the other complexes.
Likely, the presence of the pyrene and phosphonium groups in
the ligand allows the right combination of charge and
Figure 3. (a) Schematic representation of the uncaging reaction of the propargylated probe 5, and (b) imaging of the reaction in Vero cells (the first
row represents the red channel; the second row represents the merger of bright-field and red channels: (i) mock, (ii) Pd6, (iii) Pd7, and (iv) Pd8).
[Reaction conditions: 5 (50 μM) was incubated in DMEM with 5% fetal bovine serum (FBS) for 30 min. Culture medium was removed and cells
were washed twice before addition of the Pd catalyst (50 μM). Cells were then incubated for another 30 min, washed twice, and observed under the
microscope (scale bar = 20 μm).]
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hydrophobicity to favor a significant mitochondrial accumu-
lation of the complex.
Importantly, in cells treated with Pd9, we observed an
efficient transformation of 7 to 8, as deduced from the very
strong buildup of green fluorescence, that also accumulates in
the mitochondria surroundings (Figure 4c, panels (i)−(iii)).
Other phosphine-containing catalysts, such as Pd7 or Pd8,
were less active (see Figure 4d, panels (i)−(iii), as well as
Figure S21 in the Supporting Information).
Given the positive results with the rhodamine alloc probe (7)
and Pd8 and Pd9, using the inverse protocol (palladium
complexes added first), we also tested this protocol with the
rhodamine derivative having poc instead of alloc protecting
groups (Rho-poc).23 The results, which are detailed in the
Supporting Information, indicated that, while Pd8 failed to
raise significant fluorescence, Pd9 was able to promote the
depropargylation. This might be associated with a protective
effect of the mitochondria surroundings on the stability of the
palladium complex (see Figure S22 in the Supporting
Information).
■ CONCLUSIONS
Our results confirm that, while many Pd(0) and Pd(II) sources
can effect depropargylation and deallylation reactions in water
and PBS, they are much less effective in complex cellular media
or living cells. However, palladium complexes featuring
designed phosphine ligands can promote the transformations
in cell lysates with variable efficiencies, which are dependent on
the characteristics of the ligands. Despite this modest activity,
these palladium phosphine complexes can be translated to
living mammalian cells and promote both depropagylation and
alloc cleavage reactions.
Figure 4. (a) Representation of the uncaging reaction. (b) Co-localization of Pd9 with TMRE in HeLa cells, observed 2 h after incubation with the
palladium complex: (i) blue light emission of Pd9; (ii) red light emission from the mitochondrial dye TMRE; and (iii) merged image of (i) and (ii).
(c) Reaction promoted by Pd9: (i) blue light emission of Pd9, (ii) green light emission from released 8, (iii) merged image of (i) and (ii). (d)
Reaction promoted by Pd7: (i) blue channel, (ii) green light emission from released 8, (iii) merged image of (i) and (ii). (e) Graphical
representation of the ICP-MS results from mitochondrial isolation of fractioned Vero cells using complexes Pd6−Pd9 (see the Supporting
Information for details). [Reaction conditions: Pd complexes (50 μM) were incubated with HeLa cells in DMEM with 5% FBS for 2 h at 37 °C
before substrate 7 (50 μM) was added; the cells were incubated for another 30 min and observed under the microscope (scale bar = 20 μm).]
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We have also demonstrated that, using a phosphine ligand
tethered to phosphonium and hydrophobic pyrene groups, the
palladium complex presents a preferencial accumulation in
mithochondria, wherein it remains active. This type of
subcellular targeting might open new opportunites for
promoting enhanced and selective biological effects in prodrug
activation processes. Our results confirm the viability of
engineering well-defined, discrete palladium complexes to
promote relevant reactions in cellular milieu. The small-size
and ligand tunability of these complexes can offer advantages
with respect to other alternatives based on metalloenzymes or
nanoconstructs, in terms of simplicity and synthetic access, as
well as of controlling properties such as reactivity, targetability,
and cellular uptake.
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